We are live on
!
Find out more
5VM
5AM Venture Management Portfolio holdings
AUM
$360M
1-Year Est. Return
345.76%
This Fund
S&P 500
This Quarter
Est. Return
-22.04%
1 Year Est. Return
+345.76%
3 Year Est. Return
+491.51%
5 Year Est. Return
+330.26%
10 Year Est. Return
–
AUM
$323M
AUM Growth
-$142M
(-31%)
Cap. Flow
-$28M
Cap. Flow
% of AUM
-8.66%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
2
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Arvinas
ARVN
|
+$17.7M |
| 2 |
Crinetics Pharmaceuticals
CRNX
|
+$10.2M |
| 3 |
VIVE
VIVEVE MED INC
VIVE
|
+$10K |
Sector Composition
| 1 | Healthcare | 100% |
Similar funds
LSC
BWM
LC
WIP
RA
SWM
PWM
NC
5AM Venture Management's Q1 2020 Portfolio in Review
As of Q1 2020, 5AM Venture Management held 9 positions worth $323M, down 31% from $465M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
5AM Venture Management withdrew a net $28M in Q1 2020, closing 1 position and reducing 2 holdings. Its most notable exit was VIVEVE MED INC, an estimated $10K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- 5AM Venture Management's biggest Q1 2020 reduction was Arvinas, cutting an estimated $17.7M.
- 5AM Venture Management fully exited VIVEVE MED INC in Q1 2020, selling an estimated $10K.
- 5AM Venture Management's ten largest holdings make up 100% of its $323M portfolio in Q1 2020.
- 5AM Venture Management opened 0 new positions and closed 1 in Q1 2020.
- 5AM Venture Management's portfolio value fell 31% quarter-over-quarter to $323M.
Based on 5AM Venture Management's 13F filing for Q1 2020, filed 29 Apr 2020.